Literature DB >> 21128771

Cellular heterogeneity in vertical growth phase melanoma.

Alvaro C Laga1, George F Murphy.   

Abstract

CONTEXT: Melanoma growing as a tumorigenic nodule is one of the most virulent neoplasms to which the flesh is heir. At a considerably small tumor size, it incurs significant risk for widespread metastatic dissemination. There are no effective means of surgical intervention, chemical therapy, or immunologic therapy for advanced and metastatic melanoma.
OBJECTIVE: To review the literature and highlight recent cardinal advances in the understanding of melanoma vertical growth, with specific emphasis on how its recognition and characterization may be applied to diagnostic practice and development of novel investigative approaches. DATA SOURCES: Literature review, archival material, personal experience, and research collaborators.
CONCLUSIONS: The study of tumorigenic melanoma, both in primary lesions and in metastases, is the key to the eventual eradication of this highly virulent neoplasm that may disseminate widely when only occupying the volume of a grain of rice. Morphology often provides the first insight into structure and function. A growing database using meticulous and inclusive criteria to define tumor stem cells in the context of clinically relevant models now indicates that the key to melanoma heterogeneity may reside in a small subpopulation with the ability to self-renew and form tumors despite most cells present being significantly less virulent. Hopefully, from these insights into melanoma tumor progression from radial growth phase to heterogeneous and tumorigenic vertical growth phase will come additional answers to how smart therapies may be developed that specifically target those vertical growth phase cells that most pertain to patient survival.

Entities:  

Mesh:

Year:  2010        PMID: 21128771     DOI: 10.5858/2009-0394-RAR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

Review 1.  Stem cells and targeted approaches to melanoma cure.

Authors:  George F Murphy; Brian J Wilson; Sasha D Girouard; Natasha Y Frank; Markus H Frank
Journal:  Mol Aspects Med       Date:  2013-10-19

2.  An observational study regarding the rate of growth in vertical and radial growth phase superficial spreading melanomas.

Authors:  Roberto Betti; Elena Agape; Raffaella Vergani; Laura Moneghini; Amilcare Cerri
Journal:  Oncol Lett       Date:  2016-07-05       Impact factor: 2.967

3.  The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution.

Authors:  Ajit J Nirmal; Zoltan Maliga; Tuulia Vallius; Sandro Santagata; Peter K Sorger; Brian Quattrochi; Alyce A Chen; Connor A Jacobson; Roxanne J Pelletier; Clarence Yapp; Raquel Arias-Camison; Yu-An Chen; Christine G Lian; George F Murphy
Journal:  Cancer Discov       Date:  2022-06-02       Impact factor: 38.272

4.  Nestin depletion induces melanoma matrix metalloproteinases and invasion.

Authors:  Chung-Wei Lee; Qian Zhan; Cecilia Lezcano; Markus H Frank; John Huang; Allison R Larson; Jennifer Y Lin; Marilyn T Wan; Ping-I Lin; Jie Ma; Sonja Kleffel; Tobias Schatton; Christine G Lian; George F Murphy
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

5.  Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.

Authors:  Yuval Peretz; Hong Wu; Shayan Patel; Alfonso Bellacosa; Richard A Katz
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

6.  Metastatic melanoma cells evade immune detection by silencing STAT1.

Authors:  JoDi Lynn Osborn; Susanna F Greer
Journal:  Int J Mol Sci       Date:  2015-02-17       Impact factor: 5.923

7.  Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance.

Authors:  Gina Lee; Robert R Hall; Atique U Ahmed
Journal:  J Stem Cell Res Ther       Date:  2016-10-26

8.  A new strategy using ALDHhigh-CD8+T cells to inhibit tumorigenesis.

Authors:  Huiyan Luo; Changqing Zeng; Cheng Fang; Sharvesh Raj Seeruttun; Lin Lv; Wei Wang
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

9.  Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts.

Authors:  Ruixia Huang; Lise Mari K Andersen; Einar K Rofstad
Journal:  J Transl Med       Date:  2017-10-10       Impact factor: 5.531

10.  Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.

Authors:  Maria Cristina Rapanotti; Elena Campione; Tara Mayte Suarez Viguria; Giulia Spallone; Gaetana Costanza; Piero Rossi; Augusto Orlandi; Piera Valenti; Sergio Bernardini; Luca Bianchi
Journal:  Front Mol Biosci       Date:  2020-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.